ARCUS BIOSCIENCES INC's ticker is RCUS and the CUSIP is 03969F109. A total of 182 filers reported holding ARCUS BIOSCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $1,362,068 | -37.6% | 65,864 | -21.1% | 0.02% | -41.9% |
| Q3 2022 | $2,184,000 | -4.3% | 83,500 | -7.3% | 0.03% | -3.1% |
| Q2 2022 | $2,283,000 | -35.2% | 90,100 | -19.3% | 0.03% | -22.0% |
| Q1 2022 | $3,525,000 | -0.5% | 111,700 | +27.7% | 0.04% | +13.9% |
| Q4 2021 | $3,541,000 | +7.2% | 87,500 | -7.6% | 0.04% | +5.9% |
| Q3 2021 | $3,302,000 | +60.3% | 94,700 | +26.3% | 0.03% | +70.0% |
| Q2 2021 | $2,060,000 | -2.2% | 75,000 | 0.0% | 0.02% | -9.1% |
| Q1 2021 | $2,106,000 | +59.1% | 75,000 | +47.1% | 0.02% | +46.7% |
| Q4 2020 | $1,324,000 | – | 51,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 1,612,077 | $50,877,000 | 22.64% |
| Octagon Capital Advisors LP | 2,489,974 | $78,584,000 | 16.99% |
| Decheng Capital Management III (Cayman), LLC | 869,790 | $27,451,000 | 8.41% |
| BVF INC/IL | 3,960,948 | $125,008,000 | 5.00% |
| PFM Health Sciences, LP | 3,431,010 | $108,283,000 | 4.05% |
| EcoR1 Capital, LLC | 3,265,101 | $103,047,000 | 3.22% |
| Alphabet Inc. | 2,563,441 | $80,902,000 | 2.62% |
| Boxer Capital, LLC | 1,432,200 | $45,200,000 | 2.32% |
| SECTORAL ASSET MANAGEMENT INC | 338,480 | $10,682,000 | 1.90% |
| PARK CIRCLE Co | 64,000 | $2,020,000 | 1.68% |